AMNEAL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $3.47B
Liabilities Breakdown FY2023
Total Liabilities: $3.45B
Asset Breakdown
Total Assets: $3.47B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $91.5M | 2.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $581.4M | 16.7% |
| Property, Plant & Equipment | $447.6M | 12.9% |
| Goodwill | $598.6M | 17.2% |
| Intangible Assets | $890.4M | 25.6% |
| Other Assets | $863.0M | 24.9% |
Liabilities Breakdown
Total Liabilities: $3.45B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $2.39B | 69.1% |
| Other Liabilities | $1.07B | 30.9% |